Search research articles
Contact Us
Filters
Showing results (191-200 of 200) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 200 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group
K Furuse, M Fukuoka, M Kuba, et al.
Investigational New Drugs
|
June 9, 1999
Phase I and pharmacologic study of oral (E)-2'-deoxy-2'-(fluoromethylene) cytidine: on a daily x 5-day schedule
N Masuda, S Negoro, K Takeda, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer
K Kubota, K Furuse, M Kawahara, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes
|
April 30, 1996
Application of N-terminally truncated DNA polymerase from Thermus thermophilus (delta Tth polymerase) to DNA sequencing and polymerase chain reactions: comparative study of delta Tth and wild-type Tth polymerases
T Arakawa, B Jongsareejit, Y Tatsumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer
N Masuda, K Matsui, S Negoro, et al.
Japanese Journal of Cancer Research : Gann
|
July 1, 1996
Determinants of myelosuppression in the treatment of non-small cell lung cancer with cisplatin-containing chemotherapy
K Matsui, N Masuda, Y Uchida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2009
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel
I Sekine, Y Ichinose, Y Nishiwaki, et al.
Circulation
|
August 29, 2001
Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase
S Negoro, K Kunisada, Y Fujio, et al.
British Journal of Cancer
|
February 20, 2008
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
K Tamura, I Okamoto, T Kashii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule
N Masuda, K Matsui, N Yamamoto, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 200) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 200 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group
K Furuse, M Fukuoka, M Kuba, et al.
Investigational New Drugs
|
June 9, 1999
Phase I and pharmacologic study of oral (E)-2'-deoxy-2'-(fluoromethylene) cytidine: on a daily x 5-day schedule
N Masuda, S Negoro, K Takeda, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer
K Kubota, K Furuse, M Kawahara, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes
|
April 30, 1996
Application of N-terminally truncated DNA polymerase from Thermus thermophilus (delta Tth polymerase) to DNA sequencing and polymerase chain reactions: comparative study of delta Tth and wild-type Tth polymerases
T Arakawa, B Jongsareejit, Y Tatsumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer
N Masuda, K Matsui, S Negoro, et al.
Japanese Journal of Cancer Research : Gann
|
July 1, 1996
Determinants of myelosuppression in the treatment of non-small cell lung cancer with cisplatin-containing chemotherapy
K Matsui, N Masuda, Y Uchida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2009
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel
I Sekine, Y Ichinose, Y Nishiwaki, et al.
Circulation
|
August 29, 2001
Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase
S Negoro, K Kunisada, Y Fujio, et al.
British Journal of Cancer
|
February 20, 2008
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
K Tamura, I Okamoto, T Kashii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule
N Masuda, K Matsui, N Yamamoto, et al.
Page
of 20